Effects of the effective components group of Xiaoxuming decoction on MCAO rats

Chinese Pharmaceutical Journal

Volumn 47, Issue 3, 2012, Pages 194-198

  Wang, Yue Hua ^a   He, Xiao Li ^a   Yang, Hai Guang ^a   Qin, Hai Lin ^a   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Effective components group; Middle cerebral artery occlusion(MCAO); Xiao Xu Ming decoction (XXM)

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; NYLON; PLANT MEDICINAL PRODUCT; SUPEROXIDE DISMUTASE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; XIAO XU MING DECOCTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SIZE; BRAIN TISSUE; ENZYME ACTIVITY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OPERATION DURATION; RAT; SPECTROPHOTOMETRY;

EID: 84866458903     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. DU G H. Studies on effective component group of Chinese medicine prescription [J]. Chin Tradit Pat Med, 2002, 24(11): 878-880.
2. WANG Y H, ZHANG H X, LI Q, et al. High-throughput screening assay for effective component group of Xiao-xu-ming decoction [J]. J Chin Integr Med, 2006, 4(1): 64-67.
3. LI Z H, NI K Y, DU G H. Identification of the major components in the effective component group of Xiao-xu-ming decoction by high performance liquid chromatography-electrospray ionization-mass spectromelry/mass spectrometry [J]. Chin J Analy Chem, 2007, 35(2): 233-239.
4. LONGA E Z, WEINSTEIN P R, CARLSON S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1): 84-91.
5. BEDERSON J B, PITTS L H, TSUJI M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination[J]. Stroke, 1986, 17(3): 472-476.
6. BELAYEV L, ALONSO O E, BUSTO R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model [J]. Stroke, 1996, 27(9): 1616-1622.
7. BEDERSON J B, PITTS L H, GERMANO S M, et al. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats[J]. Stroke, 1986, 17(6): 1304-1308.
8. SHEN M Q, YE Q Z, LUO Y H, et al. Protective effects of extract Ginkgo bilola on brain ischemia in rats [J]. Chin Pharm J, 2003, 38(9):673-675.
9. YIN M H, YU X H, LI Y J. Protective effects of breviscapine on cell apoptosis induced by cerebral ischemia-reperfusion in mice [J]. Chin Pharm J, 2008, 43 (3): 184-188.
10. MORO M A, CARDENAS A, HURTADO O, et al. Role of nitric oxide after brain ischaemia[J]. Cell Calcium,, 2004, 36(3-4): 265-275.
11. IADECOLA C, ZHANG F, CASEY R, et al. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia[J]. Stroke, 1996, 27(8): 1373-1380.
12. WILLMOT M, GRAY L, GIBSON C, et al. A systematic review of nitric oxide donors and L-arginine in experimental stroke: effects on infarct size and cerebral blood flow[J]. Nitric Oxide, 2005, 12(3): 141-149.
13. MATSUI T, NAGFUJI T, KUMANISHI T, et al. Role of nitric oxide in pathogenesis underlying ischemic cerebral damage [J]. Cell Mol Neurobiol, 1999, 19(1): 177-189.
14. HAN Y T, ZHANG S, ZHANG X M. Paeonol decreases the levels of nitric oxide and endothelin in focal brain ischemia reperfusion injury rats[J]. Chin Pharm J, 2007, 42 (16):1218-1220.